Home Tags Drug development

Tag: drug development

Popular Articles

Partners Group buys into CVC-backed luxury watchmaker Breitling at $3bn EV, eyeing IPO in...

Partners Group has agreed to acquire a significant minority stake in Swiss watchmaker Breitling from CVC Capital Partners as it predicts a 6% CAGR growth in the luxury watch segment between 2021 and 2024. The firms said they planned to bring the company to an IPO in a few years’ time.

CORE Industrial picks up trio of businesses to create new additive manufacturing platform

CORE Industrial Partners has formed a new additive manufacturing platform through the truple buyout of 3DXTECH, Triton 3D and Gearbox3D.

Levine Leichtman sells home healthcare franchise provider Caring Brands to Wellspring Capital

Levine Leichtman Capital Partners has continued a strong run of exits with the sale of home healthcare services franchise business Caring Brands International to Wellspring Capital Management.

Platinum seals $480m Orbit Irrigation sale after doubling adjusted EBITDA in less than three...

Platinum Equity has agreed a $480m sale of Orbit Irrigation to Husqvarna Group after less than three years in its portfolio.

HIG exits IT consulting, services specialist CONET to IK Partners

HIG Capital has sold its stake in IT consulting, systems integration and software development company CONET to fellow private equity house IK Partners.

Andreessen Horowitz said to follow $2.6bn crypto, seed fund closes with another $6.5bn double...

Venture capital investment giant Andreessen Horowitz is reportedly back eyeing another $6.5bn of capital across two new funds, having already raised about $2.6bn so far this year.

Advent eyes up to $25bn for one of private equity’s biggest ever fundraises –...

Advent International is reportedly out eyeing one of the biggest private equity fundraises in history as big firms continue to swell their investment coffers following the Covid-19 outbreak.

New VC house Asymmetric Capital Partners seals target-beating $105m debut fund close

New early-stage investment house Asymmetric Capital Partners has hit an oversubscribed $105m final close for its debut fundraise.

Ping An Insurance Group collects $750m for overseas private equity investing

Chinese insurance company Ping An Insurance Group has closed Ping An Global Equity Selection Fund II and Ping An GP Opportunities Fund with a total capital commitment of $750m.

Rival bidders EQT, Hellman & Friedman team up to raise Zooplus bid to €3.7bn

Global buyout giants Hellman & Friedman and EQT have teamed up to launch an improved cash offer for German online pet supplies retailer Zooplus at a value of €3.7bn.

Get the latest PE News & Research delivered to your inbox every morning